Search

Jiayi Wu Phones & Addresses

  • Lancaster, PA
  • Harrisburg, PA
  • New York, NY

Resumes

Resumes

Jiayi Wu Photo 1

Jiayi Wu

View page
Work:
United States
Jiayi Wu Photo 2

Jiayi Wu

View page
Jiayi Wu Photo 3

Jiayi Wu New York, NY

View page
Work:
Columbia University, Institute for Social and Economic Research and Policy

Jan 2014 to 2000
Statistical Consultant

China Merchants Bank

Jul 2012 to Jul 2013
Associate Analyst

Chinese Academy of Finance and Development

Oct 2010 to May 2012
Analyst Intern

Capgemini Consulting

Jul 2011 to Jan 2012
Consultant Intern

Youth Media CUFE University Newspaper

Sep 2009 to Jul 2011
Editor in Chief

Interdisciplinary Mathematical Contest in Modeling

Feb 2011 to Feb 2011

Education:
Central University of Finance and Economics, School of Finance
Jul 2012
B.S. in Financial Engineering

Columbia University, Graduate School of Arts and Science
New York, NY
M.A. in Statistics

Jiayi Wu Photo 4

Jiayi Wu Arlington, MA

View page
Work:
Intelligent Paper Topic Learning Project

Sep 2014 to 2000
Team Lead

Columbia University, Institute for Social and Economic Research and Policy

Jan 2014 to 2000
Statistical Consultant

TripAdvisor
Newton, MA
Jun 2014 to Aug 2014
Pricing Data Scientist Intern

Crowdnetic
New York, NY
Feb 2014 to May 2014
Data Scientist Intern

China Merchants Bank

Jul 2012 to Jul 2013
Business Analyst

Interdisciplinary Mathematical Contest in Modeling (MCM)

Jan 2011 to Feb 2011
Team Lead

Interdisciplinary Mathematical Contest in Modeling (MCM)

2011 to 2011

Education:
Columbia University, Graduate School of Arts and Science
New York, NY
Dec 2014
M.A. in Statistics

Central University of Finance and Economics, School of Finance
Jul 2012
B.S. in Financial Engineering

Publications

Us Patents

Use Of Eribulin And Poly (Adp Ribose) Polymerase (Parp) Inhibitors As Combination Therapy For The Treatment Of Cancer

View page
US Patent:
20170100368, Apr 13, 2017
Filed:
May 28, 2015
Appl. No.:
15/314200
Inventors:
David COX - Oakland NJ, US
Alton KRAMER - Weston CT, US
Sharon MCGONIGLE - Andover MA, US
Jiayi WU - Brookline MA, US
- Tokyo, JP
International Classification:
A61K 31/357
A61K 31/555
A61K 31/519
Abstract:
The invention features methods for treating cancer in a patient in need thereof by administering eribulin, in combination with one or more PARP inhibitors, and, optionally, a platinum-based antineoplastic drug, and kits therefor. The invention is based in part on the observation that combinations of eribulin mesylate, a PARP inhibitor (e.g., E7449), and, optionally, a platinum-based antineo-plastic drug (e.g., carboplatin), show improved (e.g., synergistic) antitumor effects. Therefore, the present invention features methods of preventing and treating cancer (e.g., homologous recombination (HR)-deficient cancer by the use of combinations of eribulin (e.g., eribulin mesylate) and one or more PARP inhibitors (e.g., E7449 or a pharmaceutically acceptable salt thereof (e.g., the tartrate salt), optionally in combination with a platinum-based antineoplastic drug (e.g., carboplatin).
Jiayi Wu from Lancaster, PA, age ~67 Get Report